TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Tumor, Breast|Breast Tumor|Malignant Neoplasm of Breast|Mammary Cancer|Mammary Neoplasm|Mammary Neoplasms, Human|Neoplasm, Breast
Interventions: GENETIC: HTR2 T Cells|GENETIC: HTR2 T Cells
Sponsor: Baylor College of Medicine
Collaborators: Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital Research Institute